Data / Drug companies / Henry Schein, Inc.
Henry Schein, Inc.: 208 products in the FDA NDC directory, labeler code 0404
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Henry Schein, Inc. (labeler code 0404) lists 208 products in the FDA National Drug Code Directory, covering 102 finished drugs by generic name. By type: 168 prescription drugs, 40 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 8, 2026.
The request: Watch Henry Schein, Inc. (FDA labeler code 0404): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 0404
- Products in commercial distribution
- 208
- Packages
- 234
- Finished drugs by generic name
- 102
- Prescription products
- 168
- Over the counter products
- 40
- Controlled substance products
- Schedule III 2, Schedule IV 8
- Flagged as original packager
- 42 of 42 products that carry the flag
- Started marketing in the last 12 months
- 12
- Products with a marketing end date set
- 5
- Earliest marketing start
- December 30, 2008
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 113 | 54.3% |
| New drug applications (NDA) | 49 | 23.6% |
| Over the counter monograph drugs | 36 | 17.3% |
| Other unapproved drugs | 8 | 3.8% |
| Authorized generics (NDA) | 2 | 1% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 168 | 80.8% |
| Over the counter drugs | 40 | 19.2% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 106 | 51% |
| Injection | 32 | 15.4% |
| Gel | 10 | 4.8% |
| Injection, solution, concentrate | 7 | 3.4% |
| Injection, powder, for solution | 6 | 2.9% |
| Ointment | 6 | 2.9% |
| Swab | 5 | 2.4% |
| Solution | 5 | 2.4% |
| Aerosol, foam | 4 | 1.9% |
| Liquid | 4 | 1.9% |
| Jelly | 3 | 1.4% |
| Cloth | 3 | 1.4% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ketamine hydrochloride | 0404-9759 | Injection | Generic drugs (ANDA) | September 8, 2026 |
| Ampicillin | 0404-9760 | Injection, powder, for solution | Generic drugs (ANDA) | July 31, 2026 |
| Marcaine | 0404-9779 | Injection, solution | New drug applications (NDA) | June 24, 2026 |
| Metoclopramide | 0404-9771 | Injection | Generic drugs (ANDA) | April 30, 2026 |
| Diazepam | 0404-9762 | Injection | Generic drugs (ANDA) | March 24, 2026 |
| Lidocaine hydrochloride | 0404-9763 | Injection, solution | Generic drugs (ANDA) | March 19, 2026 |
| Marcaine | 0404-9768 | Injection, solution | New drug applications (NDA) | January 26, 2026 |
| Calcium Gluconate | 0404-9764 | Injection, solution | Generic drugs (ANDA) | December 23, 2025 |
| Nalbuphine Hydrochloride | 0404-9767 | Injection | Generic drugs (ANDA) | December 11, 2025 |
| Nalbuphine Hydrochloride | 0404-9766 | Injection | Generic drugs (ANDA) | December 10, 2025 |
| Marcaine | 0404-9770 | Injection, solution | New drug applications (NDA) | December 2, 2025 |
| Diazepam | 0404-9769 | Injection | Generic drugs (ANDA) | November 18, 2025 |
| Glycopyrrolate | 0404-9777 | Injection, solution | Generic drugs (ANDA) | November 5, 2025 |
| Glycopyrrolate | 0404-9776 | Injection, solution | Generic drugs (ANDA) | November 5, 2025 |
| Amiodarone hydrochloride | 0404-9772 | Injection, solution | Generic drugs (ANDA) | October 29, 2025 |
| Naloxone hydrochloride | 0404-9773 | Injection, solution | Generic drugs (ANDA) | October 28, 2025 |
| Glycopyrrolate | 0404-9775 | Injection, solution | Generic drugs (ANDA) | October 16, 2025 |
| Sterile Water | 0404-9781 | Injection, solution | Generic drugs (ANDA) | August 28, 2025 |
| Midazolam | 0404-9780 | Injection | Generic drugs (ANDA) | June 26, 2025 |
| Atropine Sulfate | 0404-9784 | Injection, solution | Generic drugs (ANDA) | June 16, 2025 |
| Esmolol Hydrochloride | 0404-9785 | Injection, solution | Generic drugs (ANDA) | June 10, 2025 |
| Lidocaine hydrochloride | 0404-9797 | Injection, solution | Generic drugs (ANDA) | May 28, 2025 |
| Lidocaine hydrochloride | 0404-9798 | Injection, solution | Generic drugs (ANDA) | May 27, 2025 |
| Cyanocobalamin | 0404-9783 | Injection, solution | Generic drugs (ANDA) | May 8, 2025 |
| Glycopyrrolate | 0404-9782 | Injection, solution | Generic drugs (ANDA) | May 8, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.